Provided below are an analyst's forecasts of revenue, net operating profit after tax (NOPAT), and net operating assets (NOA) as of 12/31/2020 for Abbott Laboratories. Forecast Horizon Period 2022 2023 $34,608.0 $36,684.5 $38,885.5 $41,218.7 $43,691.8 $4,774.4 $5,060.9 $5,364.5 $5,686.4 $6,027.6 $44,579.0 $47,253.7 $50,089.0 $53,094.3 $56,280.0 ($ millions) Reported 2020 2021 Revenue: NOPAT: NOA: 2024 Terminal Period $44,565.6 $6,148.1 $57,405.6 The following additional information is provided (dollar and share amounts in millions). Common shares outstanding: 1,771.230 Net nonoperating obligations (NNO): $11,576.0 Noncontrolling interest (NCI): $219.0 Preferred stock: $0.0 WACC: 4.0% Terminal growth: 2.0%

Cornerstones of Financial Accounting
4th Edition
ISBN:9781337690881
Author:Jay Rich, Jeff Jones
Publisher:Jay Rich, Jeff Jones
Chapter8: Current And Contingent Liabilities
Section: Chapter Questions
Problem 2MCQ
icon
Related questions
Question
Provided below are an analyst's forecasts of revenue, net operating profit after tax (NOPAT), and net operating assets (NOA) as of 12/31/2020 for
Abbott Laboratories.
($ millions) Reported 2020 2021
Revenue:
NOPAT:
NOA:
Forecast Horizon Period
2022
2023
$34,608.0 $36,684.5 $38,885.5 $41,218.7 $43,691.8
$4,774.4 $5,060.9 $5,364.5 $5,686.4 $6,027.6
$44,579.0 $47,253.7 $50,089.0 $53,094.3 $56,280.0
2024 Terminal Period
The following additional information is provided (dollar and share amounts in millions).
Common shares outstanding: 1,771.230
Net nonoperating obligations (NNO): $11,576.0
Noncontrolling interest (NCI): $219.0
Preferred stock: $0.0
WACC: 4.0%
Terminal growth: 2.0%
According to the DCF model, what is the total value of the firm?
According to the DCF model, what is the value per share of
common stock?
Use the discounted cash flow (DCF) method to answer the following questions. Do not round intermediate calculations. All values other than per-share
amounts are shown in millions.
The company's stock closed at $123.04 on 02/19/2021, the
date the 10-K was filed with the SEC. In comparing your
valuation estimate (also known as 'intrinsic value') with the
actual stock price, was the stock overvalued or undervalued,
and why?
$44,565.6
$6,148.1
$57,405.6
$224,108.3
$119.87 V
Overvalued, because the stock price is more than intrinsic value
Transcribed Image Text:Provided below are an analyst's forecasts of revenue, net operating profit after tax (NOPAT), and net operating assets (NOA) as of 12/31/2020 for Abbott Laboratories. ($ millions) Reported 2020 2021 Revenue: NOPAT: NOA: Forecast Horizon Period 2022 2023 $34,608.0 $36,684.5 $38,885.5 $41,218.7 $43,691.8 $4,774.4 $5,060.9 $5,364.5 $5,686.4 $6,027.6 $44,579.0 $47,253.7 $50,089.0 $53,094.3 $56,280.0 2024 Terminal Period The following additional information is provided (dollar and share amounts in millions). Common shares outstanding: 1,771.230 Net nonoperating obligations (NNO): $11,576.0 Noncontrolling interest (NCI): $219.0 Preferred stock: $0.0 WACC: 4.0% Terminal growth: 2.0% According to the DCF model, what is the total value of the firm? According to the DCF model, what is the value per share of common stock? Use the discounted cash flow (DCF) method to answer the following questions. Do not round intermediate calculations. All values other than per-share amounts are shown in millions. The company's stock closed at $123.04 on 02/19/2021, the date the 10-K was filed with the SEC. In comparing your valuation estimate (also known as 'intrinsic value') with the actual stock price, was the stock overvalued or undervalued, and why? $44,565.6 $6,148.1 $57,405.6 $224,108.3 $119.87 V Overvalued, because the stock price is more than intrinsic value
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps with 2 images

Blurred answer
Knowledge Booster
Balance Sheet Analysis
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Cornerstones of Financial Accounting
Cornerstones of Financial Accounting
Accounting
ISBN:
9781337690881
Author:
Jay Rich, Jeff Jones
Publisher:
Cengage Learning